BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12916126)

  • 1. A refined estimate of the average lifetime cost of pelvic inflammatory disease.
    Yeh JM; Hook EW; Goldie SJ
    Sex Transm Dis; 2003 May; 30(5):369-78. PubMed ID: 12916126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial.
    Rein DB; Kassler WJ; Irwin KL; Rabiee L
    Obstet Gynecol; 2000 Mar; 95(3):397-402. PubMed ID: 10711551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic cost of pelvic inflammatory disease.
    Washington AE; Arno PS; Brooks MA
    JAMA; 1986 Apr; 255(13):1735-8. PubMed ID: 3951103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.
    Weström L
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):880-92. PubMed ID: 7008604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic consequences of pelvic inflammatory disease in the United States.
    Curran JW
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):848-51. PubMed ID: 7008601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women.
    Blandford JM; Gift TL
    Sex Transm Dis; 2006 Oct; 33(10 Suppl):S117-21. PubMed ID: 17003678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pelvic inflammatory disease.
    Eschenbach DA
    Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000.
    Washington AE; Katz P
    JAMA; 1991 Nov; 266(18):2565-9. PubMed ID: 1942401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
    van Valkengoed IG; Postma MJ; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of sexually transmitted bacterial infections among U.S. women in 1995.
    Miller HG; Cain VS; Rogers SM; Gribble JN; Turner CF
    Fam Plann Perspect; 1999; 31(1):4-9, 23. PubMed ID: 10029926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of pelvic inflammatory disease and associated sequelae in Canada.
    Todd MJ; Estany A; McLaren R
    Can Dis Wkly Rep; 1988 Nov; 14(45):206-8. PubMed ID: 3242899
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlamydia sequelae cost estimates used in current economic evaluations: does one-size-fit-all?
    Ong KJ; Soldan K; Jit M; Dunbar JK; Woodhall SC
    Sex Transm Infect; 2017 Feb; 93(1):18-24. PubMed ID: 27288417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing pelvic infection after abortion.
    Stevenson MM; Radcliffe KW
    Int J STD AIDS; 1995; 6(5):305-12. PubMed ID: 8547409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals.
    Smith KJ; Cook RL; Roberts MS
    Value Health; 2007; 10(5):358-66. PubMed ID: 17888100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Follow-up and counselling after pelvic inflammatory disease].
    Derniaux E; Lucereau-Barbier M; Graesslin O
    J Gynecol Obstet Biol Reprod (Paris); 2012 Dec; 41(8):922-9. PubMed ID: 23159202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. If pelvic inflammatory disease is suspected empiric treatment should be initiated.
    Abatangelo L; Okereke L; Parham-Foster C; Parrish C; Scaglione L; Zotte D; Taub LF
    J Am Acad Nurse Pract; 2010 Feb; 22(2):117-22. PubMed ID: 20132370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life utilities for pelvic inflammatory disease health states.
    Smith KJ; Tsevat J; Ness RB; Wiesenfeld HC; Roberts MS
    Sex Transm Dis; 2008 Mar; 35(3):307-11. PubMed ID: 18032995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How prevalent are symptoms and risk factors of pelvic inflammatory disease in a sexually conservative population.
    Al-Kuran O; Al-Mehaisen L; Alduraidi H; Al-Husban N; Attarakih B; Sultan A; Othman Z; AlShárat S; AlHilali S; Alkouz N; Alibrahim N; AlMusallam W
    Reprod Health; 2021 May; 18(1):109. PubMed ID: 34049572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease.
    Ness RB; Randall H; Richter HE; Peipert JF; Montagno A; Soper DE; Sweet RL; Nelson DB; Schubeck D; Hendrix SL; Bass DC; Kip KE;
    Am J Public Health; 2004 Aug; 94(8):1327-9. PubMed ID: 15284036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The etiology of pelvic inflammatory disease.
    Keith L; Berger GS
    Res Front Fertil Regul; 1984 May; 3(1):1-16. PubMed ID: 12179634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.